-->
pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-122 |
Genomic Coordinates | chr18: 58451074 - 58451158 |
Synonyms | MIR122A, MIRN122, MIRN122A, hsa-mir-122, miRNA122, miRNA122A, MIR122 |
Description | Homo sapiens miR-122 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-122-5p | |||||||||||||||||||||
Sequence | 15| UGGAGUGUGACAAUGGUGUUUG |36 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
Circulating MicroRNA Expression Profiling | Circulating MicroRNA Expression Profiling |
---|
Gene Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NAA50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | MAK3, NAT13, NAT13P, NAT5, NAT5P, SAN | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description | N(alpha)-acetyltransferase 50, NatE catalytic subunit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_025146 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on NAA50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of NAA50 (miRNA target sites are highlighted) |
>NAA50|NM_025146|3'UTR 1 ACAAATTACAAATGAACTTTCTTGCACTTGCTTGTCGCCAAATAAAAGAGAGGCCCATTGATTCCTCCCCCACCCCAACA 81 CTTTTCTTTTAAAGCTTTTCTCCCTCCTTGTTCTTGTTTTTCTTTCTTCCTTTCCTTTTCTCTGAGAGTTTTAATACTTT 161 CAAGGACTTTAAAAAAATAATCATGTTTGAATTGTTTTCTCTTATTTTTGTGAGGTGGTTTGAAGGAAGGACAAGGTAGA 241 TCTGTTTAGTTTTGCAGTTGAAGTTAGATGGTCCTAAACATTTAATTGTCAAATAATTTCAAATTTAATGTCCTGCTTTC 321 ACATTGAAGGGCAGAGCCTACAAAACATTGTATATTTCAAAAGACAAAAAGAAGCAGCAGCAGTATCTTGTTCTCTAATT 401 CATAGACAAGTTGAGTGTGTTTGTGGTACTTTGGGTTTTTAAACACTTTGGGATACTAATCCCTAGACATTGCCTTCACT 481 CCACCTTTAGTCCTTCTGAGCACTCTCTCGGGAGTTGGAACATTGTTATCCTTGTAAGAAATACTAAGCTTATGTTGATT 561 TTTAAGTAATTATATCTTCTCTTCTTGCTGGTGGGTGGGGCAGTTTGGTTTAGTGTTATACTTTGGTCTAAGTATTTGAG 641 TTAAACTGCTTTTTTGCTAATGAGTGGGCTGGTTGTTAGCAGGTTTGTTTTTCCTGCTGTTGATTGTTACTAGTGGCATT 721 AACTTTTAGAATTTGGGCTGGTGAGATTAATTTTTTTTAATATCCCAGCTAGAGATATGGCCTTTAACTGACCTAAAGAG 801 GTGTGTTGTGATTTAATTTTTTCCCGTTCCTTTTTCTTCAGTAAACCCAACAATAGTCTAACCTTAAAAATTGAGTTGAT 881 GTCCTTATAGGTCACTACCCCTAAATAAACCTGAAGCAGGTGTTTTCTCTTGGACATACTAAAAAATACCTAAAAGGAAG 961 CTTAGATGGGCTGTGACACAAAAAATTCAATTACTGTCATCTAATGCCAGCTGTTAAAAGTGTGGCCACTGAGCATTTGA 1041 TTTTATAGGAAAAAATAGTATTTTTGAGAATAACATAGCTGTGCTATTGCACATCTGTTGGAGGACATCCCAGATTTGCT 1121 TATACTCAGTGCCTGTGATATTGAGTTTAAGGATTTGAGGCAGGGGTAATTATTAAACATATTGCTTCTATTCTTGGAAA 1201 AATAGAAGTGTAAAATGTTAATAATACAAATGTCACTGTGACCTCCTCCACTGAGAGGACTGGTTTATGCCAGATCATTT 1281 TCCGGCACACACGGAGTGGCTTTGACAGATTGATAACTTTGTAAGATGGGAGACATCTGAAATATTCATGTTTTCCTTTT 1361 GTAGTCCCATCTCCACTATTTAGAAATGTTCTCAGACTTTAAAATAATGCACAGGGCTTGAGCTTTCTGTCATTTGACTT 1441 TAAAAGGAAGTTTCATTCATATTTATCCTCTTATGTAAAATTGCGGTATAAAGTCTCATTTCCAAATATGTTAAATGACA 1521 AAATTATTTTATAAAATGTTTATGCACACTTTATAACCTTAAGTTTTTATTTGAGAATGTGAAAGTACAAAGTGCAGTAG 1601 ACTTCAACAATCTTGAGTGCCAAGAATAATACAGAAAAAGAAGACAGTTGATGAATGAGTTTATAGGGTTCTAATCTTAA 1681 GATGGTAAAAATGTAGAAAGACCTTGCTGGTTTTTTGGGGGTATTCGTTTCTTAAACAATCCAAATCTAAGCTTAGAAGA 1761 AAAGTTTAGCGTTAAGCACCTTTATCTTCATGAATAAGCTTCAGCTTGCTCTTGGCAAGAGAAGAGTGCTTGAGTTACAG 1841 AAGGCATAAGTAGTTTGAAGAATGCAGCAGCCTTTTTGTAAACTTCCCAGATATCAAAATAGACTTTGATATATAAATGG 1921 TTTTCTGAGATGACACTGCCTCTATTTCTATAACCATTTCACCTGGACTATCTAATCAGTCCTATGAATGTATCCCTAAA 2001 TGTGGTTATTGAAAACCTAATAGCTGCCTCATGACAAGTACATGTTATTTAAGGAGGAAAAAATATTAAATTTTGAATTG 2081 AGTGTGTAGGCTCCCTATCATTATATATAGAGTTTCTTTTTCCACGGTAGTCAGTGACTTAACCTGAATTGTAAATGTTT 2161 GTAAAGGGTTAATTGTCCTACATCAAACTTAGTTAAATAATTCCATCCACTTATGGAGGAGGAGGAGAATGTGGAAGAGG 2241 TAAAAAGCTGGGCACAAGTTCATATGCCTATGAGTCAGTAAAGACTGAAGTAATGTCCTATGTTGAGCTGGTTATTTTGA 2321 TATATGATAATAATTATCTTTGAAGTAGAACAATTCTGTTAACTGGAAAATCACAGGATATATCCATCATATTTTTCAGG 2401 ACAGATAGTTTTTACTGTGGGGCAAATAGGTTAAAATTACACTATGTTAGTTGCATTTAGGTTTTAAAGCAAAGAATCTG 2481 TAGAGAAATCTATGCAATATATAGTTTGTCCAGATTAGCTTTCATTTGGGGAATGAAGTTCTGAAATATCTAAAGCAGTT 2561 TACTCATCAATTGAAAAGTCCTCCAAAAAGAGAACTATTGGGAAACCATGGTGTGGTGGTGGAAAAGAAAAGCTCCCTCA 2641 GTTTTTTGGAGGGAATAACTTAAAAAAATACTTAAATGGCTAAGTTTACTTGGTGCAGTTAAGAATTAAACTTGTCAATT 2721 TTAACATTGCTGTTACATCTGAAATAAACTTATGTGATGTTCTGGTAGTGATCTGTGATATCTGTAAATGTCAAAACTGT 2801 ATTGTTGAATTCTGCAGCCAGCAACCGTACATACTCATTGTGTAGTGTTTCCCTTACTGCTTTTATTTACTTTCACATTT 2881 AAGATCTAATTTTAAAATCATTAAAATAGGCCAAGTGTAATTAAGGCATCCTAATTCAGATCTTCTGTGACTTGCTAGGT 2961 ACAGTGCCCAATATCTACAATTCAGTTCCAATGAGAGGGAAAAAGTAAGATCCAAGGAACTGTCTTGCTGCTGTATTTTT 3041 AATGTAATTATTAGAAATACTTGACACTTTAGGCTGCAATCTAGTTAGTAATGTTTATTGGCTACAGACAACATATTCAG 3121 GTGTTTTGTTTTTCTTCCTTGTAAGGAAGGAGTACGGTAGTTCAATGAGTTGGGAATTGGCTTTTAAGCTTTTTATCAAA 3201 CATGAATTTAAGATTTTTTCTTTAACAGAATTCAGTATTTAATATTTCTAGTCAAAATTGTTATAATTAGATTTTTGCTT 3281 TTTTCATTTAAGAAGCAATGAGTGATCCTTGTCTAGTGTGTCTCAGTTATTACTGTAGTTTAAAACAACAAACAAGTATT 3361 ACCTTCCACAGTTCTGGATCAGGAATCTAGGAGCTGCTTAACTGGGTGGTTCTGTCTTGAGATCTCAGAAGGTTGCAGTC 3441 AAGCTGTTAGCCAGGACTGTACCATCTTGAAGCTTGACAAGGCTAGAGGAGCCATTTCCAAGATGTCTTGCTTACGTGGC 3521 TCTTGGGCTTCTGTTCCTCACTGTGTGGGTATCACACACAGTGCCTGATGCTCACGTGGCTCTTGGGCTTCAGTTCCTTG 3601 GGCACCAGTTGCCTGGTGGACAACTGGTATGTGGCTTCCCCTAGAGCAGGTGATATAAGAAAGTGAGCAGAAACCATACT 3681 TTTTTATGACGTAGCCTCAGGTGACATTATTTCTGCCATATTCCATGAGTCACACAGACCAACCATTGAATCAGCTTGGT 3761 ATAGTGTGGGAGGGGACTGCACAAGGATGTGAATACTGGGAGGTGGATATCATTGGGCCCTCTAGGAGACTGGCTATCAC 3841 TGCTCAGAGAAGATGCTGGGCTTCGTTGACTCCCAAGGTCAGGGTAGTTTTGGTTAGGTTGTGTTTTATTAGTCTCTAAA 3921 AGGAGTAGTTTTCTAAATGAGGGTTATAAAGCACTGCACTTTACAGTTATTCGGGATATAAAAGAAATAGTGGGTCTAAA 4001 GGCTGTGCTCTTGTGGTTGGGTTTTCAGTGGGGAGGGGAGACTAGTCTGTCTCAGACTGATGCTGTTCTCACTGATTTGA 4081 ATATTTCTGGGAAATTGGATACTACAGTCACAAATAGGAACAGTAAGCCTATAGAAGTTTTTCAGGGAGTAAATATTTTC 4161 TATGGCAGTGTCCTGAATTGGTTCTCCCTTGCAAGACTGAACTGTAGGAACTTAGTCCTAGTTTATGATACAGCCAAGTA 4241 ACATAGTCACATGGGAAAAAGAGCTTGAGTCAGATTTCTTAATGTGTGTTGTTAACTTGGTAGAACATTGAGAATTATTT 4321 AAGTCAGAGAACGATCTGTTACTGGGGCAGAAATTCTCAACCTTTTCAGTTCTCCAAAATTTAAGATACTTGATTTCTTA 4401 GGTAAAATGTTTTTGTTTTTGTTTTGGAGACAGAGTCTCGCTCTGTCGCCCAGGCTGGAGTGCAGTGGCGCGATCTTGGC 4481 TCACTGCAAACTCCGCCTCCCAGATTCAAGCAATTCTGCCTGAGCCTCCCAAGTAGCTGCGACTAGAAAGCGCATGCCAC 4561 CACGCCTGGCTAATTTTTTGTATTTTAGTAGAGATGGGGGTTTCACCGTGTTGCCCAGGCTGGTCTCAAACTCCTGAGCT 4641 TAGGCAATCCTCCTGGGGCAGCCTCCCAAAGTGCTAGGATTACAGGCGAGCCATGGCGCCTGGCCAGTAAAATGTTTTCT 4721 ATCTAGAATGAATCAAGGTATTTTCCTTGCTCAGTAGCTTCTAGAATAAGAAAAAAATAGCAGCAAGATCTGATTCAGAA 4801 ATAGTTGGGAGCAGAAAGTTAATATGAAGGAGTTGCTACTTGTTAACAGCCTAGAGTTGAGATCTAGAAGAATTATTACC 4881 TTTTTAAATTTGTGATGAAAGCTTAAATCCAGCATTTGGGAAGTTACTCTATTGGCTGAACTATTTTGGAGTTTGTAAGC 4961 TTTGTATTAGATATTCCTGATTTAACTGAAACTAATTTGCCACATAGCTTTAATTTCATCCCAGTTTTACTTGTTTTACT 5041 GTCCTCAAAAACTCAAGACATCTGAACTCAAAGGATCTAAGCAGTATAAATTAAAGCACATGTTGAATCACTGTAGCTTT 5121 CGTAGGACATCTGATTATAATGCTTTTCTTTGTTTCTTTGTCCATACTGAACTTGTCTAGTTTATCTTTGAGAAACATTT 5201 GCTAGTATCAAAAATCTTCTGTAAAGATTTGAACAATCTTGAATTCTCCTTGTCACTAGCCATCTCTTCCCCTAAAGTAT 5281 AATAAAACTGTCAGGTACTAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
DRVs in gene 3'UTRs |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
HITS-CLIP data was present in GSM1084079. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084065 | |
Method / RBP | HITS-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000240922.3 | 3UTR | AGAGGUUGCACUCCAGCCUGGGCAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1084079 | |
Method / RBP | HITS-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000240922.3 | 3UTR | CAGAGGUUGCACUCCAGCCUGGGCAAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT000012 | CYP7A1 | cytochrome P450 family 7 subfamily A member 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT000364 | IGF1R | insulin like growth factor 1 receptor | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT000365 | SRF | serum response factor | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT000663 | RAC1 | Rac family small GTPase 1 | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 2 | |||
MIRT000717 | RHOA | ras homolog family member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT003006 | CCNG1 | cyclin G1 | ![]() |
![]() |
![]() |
![]() |
4 | 4 | ||||
MIRT003079 | GTF2B | general transcription factor IIB | ![]() |
![]() |
2 | 1 | ||||||
MIRT003080 | GYS1 | glycogen synthase 1 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT003081 | ANK2 | ankyrin 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003082 | NFATC2IP | nuclear factor of activated T-cells 2 interacting protein | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003083 | ENTPD4 | ectonucleoside triphosphate diphosphohydrolase 4 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT003084 | ANXA11 | annexin A11 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT003085 | ALDOA | aldolase, fructose-bisphosphate A | ![]() |
![]() |
![]() |
3 | 2 | |||||
MIRT003086 | RAB6B | RAB6B, member RAS oncogene family | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003087 | RAB11FIP1 | RAB11 family interacting protein 1 | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 3 | |||
MIRT003088 | FOXP1 | forkhead box P1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003089 | MECP2 | methyl-CpG binding protein 2 | ![]() |
![]() |
![]() |
3 | 2 | |||||
MIRT003090 | NCAM1 | neural cell adhesion molecule 1 | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT003091 | UBAP2 | ubiquitin associated protein 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003092 | TBX19 | T-box 19 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003093 | AACS | acetoacetyl-CoA synthetase | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003094 | DUSP2 | dual specificity phosphatase 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003095 | ATP1A2 | ATPase Na+/K+ transporting subunit alpha 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003097 | MAPK11 | mitogen-activated protein kinase 11 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003098 | FUNDC2 | FUN14 domain containing 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003099 | AKT3 | AKT serine/threonine kinase 3 | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT003100 | TPD52L2 | tumor protein D52 like 2 | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT003102 | GALNT10 | polypeptide N-acetylgalactosaminyltransferase 10 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT003103 | G6PC3 | glucose-6-phosphatase catalytic subunit 3 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT003104 | AP3M2 | adaptor related protein complex 3 mu 2 subunit | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003105 | SLC7A1 | solute carrier family 7 member 1 | ![]() |
![]() |
![]() |
![]() |
4 | 4 | ||||
MIRT003106 | XPO6 | exportin 6 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003107 | FOXJ3 | forkhead box J3 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003108 | SLC7A11 | solute carrier family 7 member 11 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003109 | TRIB1 | tribbles pseudokinase 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003110 | EGLN3 | egl-9 family hypoxia inducible factor 3 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003111 | NUMBL | NUMB like, endocytic adaptor protein | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT003112 | ADAM17 | ADAM metallopeptidase domain 17 | ![]() |
![]() |
![]() |
3 | 5 | |||||
MIRT003727 | DSTYK | dual serine/threonine and tyrosine protein kinase | ![]() |
![]() |
![]() |
3 | 2 | |||||
MIRT003728 | FAM117B | family with sequence similarity 117 member B | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT004364 | BCL2L2 | BCL2 like 2 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT004527 | PRKAB1 | protein kinase AMP-activated non-catalytic subunit beta 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT004879 | ADAM10 | ADAM metallopeptidase domain 10 | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 1 | |||
MIRT005782 | ACVR1C | activin A receptor type 1C | ![]() |
1 | 1 | |||||||
MIRT006123 | PRKRA | protein activator of interferon induced protein kinase EIF2AK2 | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT006421 | WNT1 | Wnt family member 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT007007 | PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | ![]() |
1 | 1 | |||||||
MIRT007081 | NT5C3A | 5'-nucleotidase, cytosolic IIIA | ![]() |
1 | 1 | |||||||
MIRT007082 | P4HA1 | prolyl 4-hydroxylase subunit alpha 1 | ![]() |
1 | 1 | |||||||
MIRT007083 | ZNF395 | zinc finger protein 395 | ![]() |
1 | 1 | |||||||
MIRT007084 | SOCS1 | suppressor of cytokine signaling 1 | ![]() |
1 | 1 | |||||||
MIRT023217 | SSR3 | signal sequence receptor subunit 3 | ![]() |
1 | 1 | |||||||
MIRT023218 | PHOX2A | paired like homeobox 2a | ![]() |
1 | 1 | |||||||
MIRT023219 | DZIP1L | DAZ interacting zinc finger protein 1 like | ![]() |
1 | 1 | |||||||
MIRT023220 | GSTM2 | glutathione S-transferase mu 2 | ![]() |
1 | 1 | |||||||
MIRT023221 | RAI14 | retinoic acid induced 14 | ![]() |
1 | 1 | |||||||
MIRT023222 | STARD13 | StAR related lipid transfer domain containing 13 | ![]() |
1 | 1 | |||||||
MIRT023223 | CNN3 | calponin 3 | ![]() |
1 | 1 | |||||||
MIRT023224 | A2M | alpha-2-macroglobulin | ![]() |
1 | 1 | |||||||
MIRT023225 | EFCAB6 | EF-hand calcium binding domain 6 | ![]() |
1 | 1 | |||||||
MIRT023226 | GLOD4 | glyoxalase domain containing 4 | ![]() |
1 | 1 | |||||||
MIRT023227 | CALR | calreticulin | ![]() |
1 | 1 | |||||||
MIRT023228 | POFUT1 | protein O-fucosyltransferase 1 | ![]() |
1 | 1 | |||||||
MIRT023229 | PYGO1 | pygopus family PHD finger 1 | ![]() |
1 | 1 | |||||||
MIRT023230 | CDY2B | chromodomain Y-linked 2B | ![]() |
1 | 1 | |||||||
MIRT023231 | CDC42EP3 | CDC42 effector protein 3 | ![]() |
1 | 1 | |||||||
MIRT023232 | CS | citrate synthase | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT023233 | RNF170 | ring finger protein 170 | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT023234 | GTF3C6 | general transcription factor IIIC subunit 6 | ![]() |
1 | 1 | |||||||
MIRT023235 | ZNF321P | zinc finger protein 321, pseudogene | ![]() |
1 | 1 | |||||||
MIRT023236 | LAMP1 | lysosomal associated membrane protein 1 | ![]() |
1 | 1 | |||||||
MIRT023237 | SLC52A2 | solute carrier family 52 member 2 | ![]() |
1 | 1 | |||||||
MIRT023238 | ZNF658 | zinc finger protein 658 | ![]() |
1 | 1 | |||||||
MIRT023239 | ATP13A3 | ATPase 13A3 | ![]() |
1 | 1 | |||||||
MIRT023240 | CPNE5 | copine 5 | ![]() |
1 | 1 | |||||||
MIRT023241 | KATNAL1 | katanin catalytic subunit A1 like 1 | ![]() |
1 | 1 | |||||||
MIRT023242 | TMEM136 | transmembrane protein 136 | ![]() |
1 | 1 | |||||||
MIRT023243 | ATP11A | ATPase phospholipid transporting 11A | ![]() |
1 | 1 | |||||||
MIRT023244 | TMEM74 | transmembrane protein 74 | ![]() |
1 | 1 | |||||||
MIRT023245 | ANKRD10 | ankyrin repeat domain 10 | ![]() |
1 | 1 | |||||||
MIRT023246 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | ![]() |
1 | 1 | |||||||
MIRT023247 | USP10 | ubiquitin specific peptidase 10 | ![]() |
1 | 1 | |||||||
MIRT023248 | AKAP11 | A-kinase anchoring protein 11 | ![]() |
1 | 1 | |||||||
MIRT023249 | BACH2 | BTB domain and CNC homolog 2 | ![]() |
1 | 1 | |||||||
MIRT023250 | HCCS | holocytochrome c synthase | ![]() |
1 | 1 | |||||||
MIRT023251 | Slc7a1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | ![]() |
1 | 1 | |||||||
MIRT023252 | GTDC2 | protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) | ![]() |
1 | 1 | |||||||
MIRT023253 | CTPS1 | CTP synthase 1 | ![]() |
1 | 1 | |||||||
MIRT023254 | SLC44A1 | solute carrier family 44 member 1 | ![]() |
1 | 1 | |||||||
MIRT023255 | CLSPN | claspin | ![]() |
1 | 1 | |||||||
MIRT023256 | RABGEF1 | RAB guanine nucleotide exchange factor 1 | ![]() |
1 | 1 | |||||||
MIRT023257 | FBXO7 | F-box protein 7 | ![]() |
1 | 1 | |||||||
MIRT023258 | NCDN | neurochondrin | ![]() |
1 | 1 | |||||||
MIRT023259 | SOX2 | SRY-box 2 | ![]() |
1 | 1 | |||||||
MIRT023260 | ZNF618 | zinc finger protein 618 | ![]() |
1 | 1 | |||||||
MIRT023261 | ABLIM1 | actin binding LIM protein 1 | ![]() |
1 | 1 | |||||||
MIRT023262 | ZBTB4 | zinc finger and BTB domain containing 4 | ![]() |
1 | 1 | |||||||
MIRT023263 | LUZP1 | leucine zipper protein 1 | ![]() |
1 | 1 | |||||||
MIRT023264 | NLGN3 | neuroligin 3 | ![]() |
1 | 1 | |||||||
MIRT023265 | PRR11 | proline rich 11 | ![]() |
1 | 1 | |||||||
MIRT023266 | HHAT | hedgehog acyltransferase | ![]() |
1 | 1 | |||||||
MIRT023267 | UBE2L3 | ubiquitin conjugating enzyme E2 L3 | ![]() |
1 | 1 | |||||||
MIRT023268 | DNAJC18 | DnaJ heat shock protein family (Hsp40) member C18 | ![]() |
1 | 1 | |||||||
MIRT023269 | FAM102A | family with sequence similarity 102 member A | ![]() |
1 | 1 | |||||||
MIRT023270 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | ![]() |
1 | 1 | |||||||
MIRT023271 | DENND2C | DENN domain containing 2C | ![]() |
1 | 1 | |||||||
MIRT023272 | HMOX1 | heme oxygenase 1 | ![]() |
![]() |
![]() |
3 | 2 | |||||
MIRT023273 | USP28 | ubiquitin specific peptidase 28 | ![]() |
1 | 1 | |||||||
MIRT023274 | KRT18 | keratin 18 | ![]() |
1 | 1 | |||||||
MIRT023275 | BPGM | bisphosphoglycerate mutase | ![]() |
1 | 1 | |||||||
MIRT023276 | ZNF233 | zinc finger protein 233 | ![]() |
1 | 1 | |||||||
MIRT023277 | SLC25A30 | solute carrier family 25 member 30 | ![]() |
1 | 1 | |||||||
MIRT023278 | ANKRD9 | ankyrin repeat domain 9 | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT023279 | RLN1 | relaxin 1 | ![]() |
1 | 1 | |||||||
MIRT023280 | DDIT3 | DNA damage inducible transcript 3 | ![]() |
1 | 1 | |||||||
MIRT023281 | TRIM65 | tripartite motif containing 65 | ![]() |
1 | 1 | |||||||
MIRT023282 | B4GALT1 | beta-1,4-galactosyltransferase 1 | ![]() |
1 | 1 | |||||||
MIRT023283 | ANXA7 | annexin A7 | ![]() |
1 | 1 | |||||||
MIRT023284 | SLC19A2 | solute carrier family 19 member 2 | ![]() |
1 | 1 | |||||||
MIRT023285 | MARCKS | myristoylated alanine rich protein kinase C substrate | ![]() |
1 | 1 | |||||||
MIRT023286 | CLEC11A | C-type lectin domain containing 11A | ![]() |
1 | 1 | |||||||
MIRT023287 | CENPF | centromere protein F | ![]() |
1 | 1 | |||||||
MIRT023288 | CLDN18 | claudin 18 | ![]() |
1 | 1 | |||||||
MIRT023289 | PFDN1 | prefoldin subunit 1 | ![]() |
1 | 1 | |||||||
MIRT023290 | SPAG9 | sperm associated antigen 9 | ![]() |
1 | 1 | |||||||
MIRT023291 | CEACAM8 | carcinoembryonic antigen related cell adhesion molecule 8 | ![]() |
1 | 1 | |||||||
MIRT023292 | KRT10 | keratin 10 | ![]() |
1 | 1 | |||||||
MIRT023293 | SET | SET nuclear proto-oncogene | ![]() |
1 | 1 | |||||||
MIRT023294 | SLC11A2 | solute carrier family 11 member 2 | ![]() |
1 | 1 | |||||||
MIRT023295 | MYCBP | MYC binding protein | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT023296 | GPHB5 | glycoprotein hormone beta 5 | ![]() |
1 | 1 | |||||||
MIRT023297 | STAU2 | staufen double-stranded RNA binding protein 2 | ![]() |
1 | 1 | |||||||
MIRT023298 | NFATC1 | nuclear factor of activated T-cells 1 | ![]() |
1 | 1 | |||||||
MIRT023299 | ERP29 | endoplasmic reticulum protein 29 | ![]() |
1 | 1 | |||||||
MIRT023300 | MEP1A | meprin A subunit alpha | ![]() |
1 | 1 | |||||||
MIRT023301 | SPTLC1 | serine palmitoyltransferase long chain base subunit 1 | ![]() |
1 | 1 | |||||||
MIRT023302 | GTF2H2 | general transcription factor IIH subunit 2 | ![]() |
1 | 1 | |||||||
MIRT023303 | C14orf39 | chromosome 14 open reading frame 39 | ![]() |
1 | 1 | |||||||
MIRT023304 | UBE2K | ubiquitin conjugating enzyme E2 K | ![]() |
1 | 1 | |||||||
MIRT023305 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | ![]() |
1 | 1 | |||||||
MIRT023306 | PSMD10 | proteasome 26S subunit, non-ATPase 10 | ![]() |
1 | 1 | |||||||
MIRT023307 | CALD1 | caldesmon 1 | ![]() |
1 | 1 | |||||||
MIRT023308 | TTYH3 | tweety family member 3 | ![]() |
1 | 1 | |||||||
MIRT023309 | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 | ![]() |
1 | 1 | |||||||
MIRT023310 | SCN4B | sodium voltage-gated channel beta subunit 4 | ![]() |
1 | 1 | |||||||
MIRT023311 | C1orf122 | chromosome 1 open reading frame 122 | ![]() |
1 | 1 | |||||||
MIRT023312 | PAK1 | p21 (RAC1) activated kinase 1 | ![]() |
1 | 1 | |||||||
MIRT023313 | DNAJB1 | DnaJ heat shock protein family (Hsp40) member B1 | ![]() |
1 | 1 | |||||||
MIRT023314 | DMXL1 | Dmx like 1 | ![]() |
1 | 1 | |||||||
MIRT023315 | ZNF160 | zinc finger protein 160 | ![]() |
1 | 1 | |||||||
MIRT023316 | CSRP1 | cysteine and glycine rich protein 1 | ![]() |
1 | 1 | |||||||
MIRT023317 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | ![]() |
1 | 1 | |||||||
MIRT023318 | RBBP5 | RB binding protein 5, histone lysine methyltransferase complex subunit | ![]() |
1 | 1 | |||||||
MIRT023319 | ANKRD13C | ankyrin repeat domain 13C | ![]() |
1 | 1 | |||||||
MIRT023320 | SUCLA2 | succinate-CoA ligase ADP-forming beta subunit | ![]() |
1 | 1 | |||||||
MIRT023321 | PEA15 | phosphoprotein enriched in astrocytes 15 | ![]() |
1 | 1 | |||||||
MIRT023322 | MTPN | myotrophin | ![]() |
1 | 1 | |||||||
MIRT023323 | YKT6 | YKT6 v-SNARE homolog | ![]() |
1 | 1 | |||||||
MIRT023324 | MOB3B | MOB kinase activator 3B | ![]() |
1 | 1 | |||||||
MIRT023325 | FAM118A | family with sequence similarity 118 member A | ![]() |
1 | 1 | |||||||
MIRT023326 | ZNF264 | zinc finger protein 264 | ![]() |
1 | 1 | |||||||
MIRT023327 | HECTD3 | HECT domain E3 ubiquitin protein ligase 3 | ![]() |
1 | 1 | |||||||
MIRT023328 | BATF2 | basic leucine zipper ATF-like transcription factor 2 | ![]() |
1 | 1 | |||||||
MIRT023329 | PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | ![]() |
1 | 1 | |||||||
MIRT023330 | MAPRE1 | microtubule associated protein RP/EB family member 1 | ![]() |
1 | 1 | |||||||
MIRT023331 | TBC1D22B | TBC1 domain family member 22B | ![]() |
1 | 1 | |||||||
MIRT023332 | SLC9A1 | solute carrier family 9 member A1 | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT023333 | NPEPPS | aminopeptidase puromycin sensitive | ![]() |
1 | 1 | |||||||
MIRT023334 | BCL2L1 | BCL2 like 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT023335 | OSMR | oncostatin M receptor | ![]() |
1 | 1 | |||||||
MIRT023336 | CALU | calumenin | ![]() |
1 | 1 | |||||||
MIRT023337 | BRI3BP | BRI3 binding protein | ![]() |
1 | 1 | |||||||
MIRT023338 | PSPH | phosphoserine phosphatase | ![]() |
1 | 1 | |||||||
MIRT023339 | APMAP | adipocyte plasma membrane associated protein | ![]() |
1 | 1 | |||||||
MIRT023340 | WASF1 | WAS protein family member 1 | ![]() |
1 | 1 | |||||||
MIRT023341 | LCA5 | LCA5, lebercilin | ![]() |
1 | 1 | |||||||
MIRT023342 | NODAL | nodal growth differentiation factor | ![]() |
1 | 1 | |||||||
MIRT023343 | CASP7 | caspase 7 | ![]() |
1 | 1 | |||||||
MIRT023344 | CPA3 | carboxypeptidase A3 | ![]() |
1 | 1 | |||||||
MIRT023345 | PALM | paralemmin | ![]() |
1 | 1 | |||||||
MIRT023346 | TCP11 | t-complex 11 | ![]() |
1 | 1 | |||||||
MIRT023347 | NALCN | sodium leak channel, non-selective | ![]() |
1 | 1 | |||||||
MIRT023348 | PLAGL2 | PLAG1 like zinc finger 2 | ![]() |
1 | 1 | |||||||
MIRT023349 | IDS | iduronate 2-sulfatase | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT023350 | PARP11 | poly(ADP-ribose) polymerase family member 11 | ![]() |
1 | 1 | |||||||
MIRT023351 | MAZ | MYC associated zinc finger protein | ![]() |
1 | 1 | |||||||
MIRT023352 | CPNE4 | copine 4 | ![]() |
1 | 1 | |||||||
MIRT023353 | FAM19A3 | family with sequence similarity 19 member A3, C-C motif chemokine like | ![]() |
1 | 1 | |||||||
MIRT023354 | KRT14 | keratin 14 | ![]() |
1 | 1 | |||||||
MIRT023355 | DYNC1H1 | dynein cytoplasmic 1 heavy chain 1 | ![]() |
1 | 1 | |||||||
MIRT023356 | GNL3L | G protein nucleolar 3 like | ![]() |
1 | 1 | |||||||
MIRT023357 | HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | ![]() |
1 | 1 | |||||||
MIRT023358 | EYA4 | EYA transcriptional coactivator and phosphatase 4 | ![]() |
1 | 1 | |||||||
MIRT023359 | GNPDA2 | glucosamine-6-phosphate deaminase 2 | ![]() |
1 | 1 | |||||||
MIRT023360 | BRCA2 | BRCA2, DNA repair associated | ![]() |
1 | 1 | |||||||
MIRT023361 | ZSCAN4 | zinc finger and SCAN domain containing 4 | ![]() |
1 | 1 | |||||||
MIRT023362 | HSPA5 | heat shock protein family A (Hsp70) member 5 | ![]() |
1 | 1 | |||||||
MIRT023363 | SERAC1 | serine active site containing 1 | ![]() |
1 | 1 | |||||||
MIRT023364 | SLC15A2 | solute carrier family 15 member 2 | ![]() |
1 | 1 | |||||||
MIRT023365 | RABIF | RAB interacting factor | ![]() |
1 | 1 | |||||||
MIRT023366 | ART3 | ADP-ribosyltransferase 3 | ![]() |
1 | 1 | |||||||
MIRT023367 | EP400 | E1A binding protein p400 | ![]() |
1 | 1 | |||||||
MIRT023368 | MT4 | metallothionein 4 | ![]() |
1 | 1 | |||||||
MIRT023369 | TRAM2 | translocation associated membrane protein 2 | ![]() |
1 | 1 | |||||||
MIRT023370 | PHPT1 | phosphohistidine phosphatase 1 | ![]() |
1 | 1 | |||||||
MIRT023371 | KIAA0101 | PCNA clamp associated factor | ![]() |
1 | 1 | |||||||
MIRT023372 | VHL | von Hippel-Lindau tumor suppressor | ![]() |
1 | 1 | |||||||
MIRT023373 | IFNA1 | interferon alpha 1 | ![]() |
1 | 1 | |||||||
MIRT023374 | FSTL3 | follistatin like 3 | ![]() |
1 | 1 | |||||||
MIRT023375 | PHF14 | PHD finger protein 14 | ![]() |
1 | 1 | |||||||
MIRT023376 | ZCCHC2 | zinc finger CCHC-type containing 2 | ![]() |
1 | 1 | |||||||
MIRT023377 | GSTM3 | glutathione S-transferase mu 3 | ![]() |
1 | 1 | |||||||
MIRT023378 | DCTN5 | dynactin subunit 5 | ![]() |
1 | 1 | |||||||
MIRT023379 | CHST3 | carbohydrate sulfotransferase 3 | ![]() |
1 | 1 | |||||||
MIRT023380 | HECW2 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 | ![]() |
1 | 1 | |||||||
MIRT023381 | ADO | 2-aminoethanethiol dioxygenase | ![]() |
1 | 1 | |||||||
MIRT023382 | POMZP3 | POM121 and ZP3 fusion | ![]() |
1 | 1 | |||||||
MIRT023383 | CHST12 | carbohydrate sulfotransferase 12 | ![]() |
1 | 1 | |||||||
MIRT023384 | ARSB | arylsulfatase B | ![]() |
1 | 1 | |||||||
MIRT023385 | ATP7A | ATPase copper transporting alpha | ![]() |
1 | 1 | |||||||
MIRT023386 | PMP22 | peripheral myelin protein 22 | ![]() |
1 | 1 | |||||||
MIRT023387 | TGFBRAP1 | transforming growth factor beta receptor associated protein 1 | ![]() |
1 | 1 | |||||||
MIRT023388 | ORC2 | origin recognition complex subunit 2 | ![]() |
1 | 1 | |||||||
MIRT023389 | CREB1 | cAMP responsive element binding protein 1 | ![]() |
1 | 1 | |||||||
MIRT023390 | CD83 | CD83 molecule | ![]() |
1 | 1 | |||||||
MIRT023391 | TOB2 | transducer of ERBB2, 2 | ![]() |
![]() |
![]() |
3 | 5 | |||||
MIRT023392 | LRP11 | LDL receptor related protein 11 | ![]() |
1 | 1 | |||||||
MIRT023393 | MPV17 | MPV17, mitochondrial inner membrane protein | ![]() |
1 | 1 | |||||||
MIRT023394 | TRIM29 | tripartite motif containing 29 | ![]() |
1 | 1 | |||||||
MIRT023395 | OSBP2 | oxysterol binding protein 2 | ![]() |
1 | 1 | |||||||
MIRT023396 | PKM | pyruvate kinase, muscle | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
6 | 4 | ||
MIRT023397 | FOXK2 | forkhead box K2 | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT023398 | CLIC4 | chloride intracellular channel 4 | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 6 | |||
MIRT023399 | ST6GALNAC4 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 | ![]() |
1 | 1 | |||||||
MIRT023400 | SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | ![]() |
1 | 1 | |||||||
MIRT023401 | LMNB2 | lamin B2 | ![]() |
![]() |
![]() |
3 | 5 | |||||
MIRT023402 | BAX | BCL2 associated X, apoptosis regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT023403 | CDK4 | cyclin dependent kinase 4 | ![]() |
![]() |
![]() |
3 | 3 | |||||
MIRT054362 | Cux1 | cut-like homeobox 1 | ![]() |
1 | 1 | |||||||
MIRT074336 | TNRC6A | trinucleotide repeat containing 6A | ![]() |
![]() |
2 | 2 | ||||||
MIRT109185 | VMA21 | VMA21, vacuolar ATPase assembly factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT324745 | ACER2 | alkaline ceramidase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT325564 | HIATL1 | major facilitator superfamily domain containing 14B | ![]() |
![]() |
2 | 4 | ||||||
MIRT438005 | MEF2D | myocyte enhancer factor 2D | ![]() |
1 | 2 | |||||||
MIRT438206 | TGFB1 | transforming growth factor beta 1 | ![]() |
1 | 1 | |||||||
MIRT438639 | AXL | AXL receptor tyrosine kinase | ![]() |
1 | 1 | |||||||
MIRT438655 | NOD2 | nucleotide binding oligomerization domain containing 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT438734 | FUT8 | fucosyltransferase 8 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT449879 | CYP3A5 | cytochrome P450 family 3 subfamily A member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451716 | OLR1 | oxidized low density lipoprotein receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453274 | EFTUD2 | elongation factor Tu GTP binding domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454113 | MRPL52 | mitochondrial ribosomal protein L52 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454232 | OSBPL10 | oxysterol binding protein like 10 | ![]() |
![]() |
2 | 15 | ||||||
MIRT454344 | CDKL1 | cyclin dependent kinase like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455826 | ZSWIM1 | zinc finger SWIM-type containing 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT459903 | PIGO | phosphatidylinositol glycan anchor biosynthesis class O | ![]() |
![]() |
2 | 12 | ||||||
MIRT461654 | G6PC | glucose-6-phosphatase catalytic subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT461934 | TNFSF14 | TNF superfamily member 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463834 | WSB1 | WD repeat and SOCS box containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468615 | SUMO1 | small ubiquitin-like modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469456 | REL | REL proto-oncogene, NF-kB subunit | ![]() |
![]() |
2 | 6 | ||||||
MIRT469637 | RAD21 | RAD21 cohesin complex component | ![]() |
![]() |
2 | 6 | ||||||
MIRT473432 | MDM4 | MDM4, p53 regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT473872 | MAFK | MAF bZIP transcription factor K | ![]() |
![]() |
2 | 6 | ||||||
MIRT476861 | FHL2 | four and a half LIM domains 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT476893 | FBXO21 | F-box protein 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479880 | CCDC43 | coiled-coil domain containing 43 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488848 | UBTF | upstream binding transcription factor, RNA polymerase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT491164 | LRP3 | LDL receptor related protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497662 | PRMT3 | protein arginine methyltransferase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499314 | ZNF485 | zinc finger protein 485 | ![]() |
![]() |
2 | 10 | ||||||
MIRT499759 | CIRH1A | UTP4, small subunit processome component | ![]() |
![]() |
2 | 10 | ||||||
MIRT500014 | ABCF2 | ATP binding cassette subfamily F member 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT501090 | SLC7A5 | solute carrier family 7 member 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT509646 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 10 | ||||||
MIRT509945 | TOMM70A | translocase of outer mitochondrial membrane 70 | ![]() |
![]() |
2 | 6 | ||||||
MIRT510320 | SLC2A3 | solute carrier family 2 member 3 |